PRAX - Company ID 0001689548
The table below shows Praxis Precision Medicines, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$86.15M | -$53.01M | -$20.86M | -$32.85M | -$54.11M | -$25.72M |
| Capital expenditure | $62.00K | $0.00 | - | $0.00 | $289.00K | $4.00K |
| Investing cash flow | -$344.27M | -$51.06M | -$91.22M | $34.00M | -$8.55M | -$140.01M |
| Dividends paid | - | - | - |
Praxis Precision Medicines, Inc. reported operating cash flow of -$249.07M for fiscal year 2025. That is down 89.0% from -$131.76M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$33.42M (FY 2019) to -$249.07M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $609.43M | $54.27M | $182.76M | $18.07M | $1.21M | $276.00K |